跳至主要内容
临床试验/NCT06229899
NCT06229899已完成不适用

Can Follistatin Levels Help Distinguish Between Metabolically Healthy and Unhealthy Obese Individuals

Goztepe Prof Dr Suleyman Yalcın City Hospital1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2022年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62
试验地点
1
主要终点
relation between follistatin and metabolically healthy and unhealthy obesity

研究概览

简要总结

There is no clear boundary on which obese individuals should be considered metabolically healthy and which should be considered metabolically unhealthy. It is also not very clear whether the individuals who are considered metabolically healthy will remain healthy in the future. The objective of this study was to assess potential disparities in serum follistatin levels between these two distinct groups. Furthermore, the study sought to investigate whether this disparity could serve as a reliable indicator for distinguishing between metabolically healthy and unhealthy obese individuals.

详细描述

Individuals with similar body mass indexes may have different metabolic health and cardiovascular risks. Research shows that some individuals with comparable body mass index (BMI) are metabolically healthy and have a lower risk of cardiovascular issues, while others are metabolically unhealthy and have a higher risk. Studies indicate that the lifestyles of metabolically healthy and unhealthy obese individuals, such as diet, physical activity, and sleep patterns, do not differ significantly, even though the individuals have similar levels of total or subcutaneous adiposity. However, it has been shown that metabolically healthy obese individuals tend to have lower levels of visceral adiposity compared to unhealthy ones.

Patients with BMI≥30, who applied to the internal medicine clinic, were included in the study. Among these patients, those without criteria of metabolic syndrome other than an increase in waist circumference (blood pressure ≥130/85 mmHg, fasting blood sugar ≥100 mg/dl, triglycerides ≥150 mg/dl, HDL-cholesterol <40 mg/dl in men and <50 mg/dl in women) and without prediabetes were defined as metabolically healthy obese individuals. Those with at least 1 metabolic syndrome criterion other than an increase in waist circumference were classified as metabolically unhealthy obese individuals. The participants' fasting blood sugar levels, HbA1c levels, insulin levels, lipid panel results, liver enzymes levels,urea levels, creatinine levels, whole blood count, and thyroid hormones were examined. Anthropometric measurements including height,weight and waist circumference were also taken for each individual.

Participants were then invited back to repeat follistatin levels.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Having given consent to the study
  • Being over 18 years of age
  • Being under 60 years of age
  • Body mass index >=30 kg/m2

排除标准

  • Antidiabetic medication usage
  • obesity surgery
  • Antihypertensive medication usage
  • Those receiving lipid-lowering therapy
  • Pregnant women
  • Those with hypo/hyperthyroidism
  • Steroid use
  • Benign/malignant tumors
  • Advanced liver disease
  • Secondary causes of obesity

结局指标

主要结局

relation between follistatin and metabolically healthy and unhealthy obesity

时间窗: baseline

This study aims to examine the correlation between follistatin levels and both metabolically healthy and unhealthy individuals with obesity

threshold for follistatin in metabolic evaluation of obesity

时间窗: baseline

The establishment of a threshold value for follistatin levels in assessing metabolic health in obese individuals.

次要结局

未报告次要终点

研究者

发起方
Goztepe Prof Dr Suleyman Yalcın City Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayse N Erbakan

Principal investigator

Goztepe Prof Dr Suleyman Yalcın City Hospital

研究点 (1)

Loading locations...

相似试验